Delving into the Latest Updates on Suzhou Siran Biotech Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Digestive System Disorders

Cardiovascular Diseases

siRNA

Antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	3
Neoplasms	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

siRNA	4
Antibody	1

Top 5 Target	Count

PDL1(Programmed death-ligand 1)	2
ALK7(activin A receptor type 1C)	1
HBX x PDL1	1
AGT(Angiotensinogen)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

3

Preclinical

Phase 1

1

4

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SA-1211 ( HBX x PDL1 )	Hepatitis B, Chronic More	Phase 1
SA012 ( PDL1 )	Hepatitis B More	Preclinical
SA016 ( AGT )	Hypertension More	Preclinical
SA-030 ( ALK7 )	Obesity More	Preclinical
CN117881783 ( PDL1 )Patent Mining	Neoplasms More	Discovery